EIG Blog Press Release: Early is Good Receives NIH Phase 2 Grant to Develop Innovative Bladder Cancer Monitoring Test

Indianapolis, IN - October 24, 2024 - Early is Good (EIG), a life sciences company focused on developing innovative solutions enabling early cancer detection, has received a National Institutes of Health (NIH) Phase 2 grant of $1.6M in non-dilutive funding to support validation efforts of its bladder cancer monitoring test, BCDx. This non-invasive urine test [...]